Simple exploration of (Tetrahydrofuran-3-yl)methanol

We’ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 15833-61-1, and how the biochemistry of the body works.Quality Control of (Tetrahydrofuran-3-yl)methanol

In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 15833-61-1, name is (Tetrahydrofuran-3-yl)methanol, introducing its new discovery. Safety of (Tetrahydrofuran-3-yl)methanol

There is provided a novel compound that inhibits phosphatidylinositol 3-kinase (PI3K) and/or the mammalian target of rapamycin (mTOR) and exhibits anti-tumor activity. The present invention provides a compound represented by the following formula (1) having various substituents that inhibits PI3K and/or mTOR and exhibits anti-tumor activity: wherein R1, R2, R3, R4, Ra, Rb, Rc, and X each have the same meaning as defined in the specification.

We’ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 15833-61-1, and how the biochemistry of the body works.Quality Control of (Tetrahydrofuran-3-yl)methanol

Reference：
Tetrahydrofuran – Wikipedia,
Tetrahydrofuran | (CH2)3CH2O – PubChem